Cefepime Mylan

Страна: Нова Зеландия

Език: английски

Източник: Medsafe (Medicines Safety Authority)

Купи го сега

Активна съставка:

Cefepime dihydrochloride monohydrate 2.30368 g equivalent to 2 g cefepime free base; Cefepime dihydrochloride monohydrate 2.378 g equivalent to 2 g cefepime free base

Предлага се от:

Viatris Limited

INN (Международно Name):

Cefepime dihydrochloride monohydrate 2.30368 g (equivalent to 2 g cefepime free base)

дозиране:

2 g

Лекарствена форма:

Powder for injection

Композиция:

Active: Cefepime dihydrochloride monohydrate 2.30368 g equivalent to 2 g cefepime free base Excipient: Arginine Active: Cefepime dihydrochloride monohydrate 2.378 g equivalent to 2 g cefepime free base Excipient: Arginine

Броя в опаковка:

Vial, glass, single dose, Type 1 clear glass vial with grey bromo butyl rubber stopper, 2 g

Клас:

Prescription

Вид предписание :

Prescription

Произведено от:

Fresenius Kabi Anti-Infectives S.r.l.

Терапевтични показания:

CEFEPIME Mylan is indicated in adults for the treatment of the infections listed below when caused by susceptible bacteria. · Lower respiratory tract infections, including pneumonia and bronchitis. · Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections. · Skin and skin structure infections. · Septicaemia. · Intra-abdominal infections, including peritonitis and biliary tract infections. · Empiric treatment of febrile neutropenia.

Каталог на резюме:

Package - Contents - Shelf Life: Vial, glass, single dose, Type I clear glass vial with grey bromo butyl rubber stopper and flip off aluminium seal - 2 g - 2 years from date of manufacture stored at or below 25°C protect from light 24 hours reconstituted stored at or below 25°C protect from light 168 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) protect from light

Дата Оторизация:

2009-06-17

Преглед на историята на документите